BamSEC and AlphaSense Join Forces
Learn More

MDNA Life Sciences, Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.20
from S-1/A 3 pages Re: Agreement to Convert Deferred Compensation to Common Stock 1
12/34/56
EX-10.19
from S-1/A 14 pages Common Stock Purchase Warrant MDNA Life Sciences, Inc
12/34/56
EX-10.18
from S-1/A 14 pages 12% Convertible Promissory Note Due June 1, 2023
12/34/56
EX-10.17
from S-1/A 21 pages Securities Purchase Agreement
12/34/56
EX-10.16
from S-1/A 6 pages Executive Employment Agreement
12/34/56
EX-10.15
from S-1 3 pages Second Amendment to December 22, 2017 License Agreement
12/34/56
EX-10.14
from S-1 ~1 page First Amendment to December 22, 2017 License Agreement
12/34/56
EX-10.13
from S-1 17 pages License Agreement
12/34/56
EX-10.12
from S-1 102 pages Dated 21 March 2019 Lease Relating to Level One the Biosphere Newcastle Helix Newcastle Upon Tyne Between the Council of the City of Newcastle Upon Tyne and Mdna Life Sciences (Uk) Limited and MDNA Life Sciences Inc Assistant Director Legal Services Civic Centre Newcastle Upon Tyne Ne1 8qh
12/34/56
EX-10.11
from S-1 31 pages Dated 2020 Lease Relating to Suite/Unit R.01.24, R.01.25, R.01.45 the Biosphere Draymans Way Newcastle Helix Newcastle Upon Tyne Ne4 5bx Between (1) the Council of the City of Newcastle Upon Tyne and (2) MDNA Life Sciences (Uk) Limited Assistant Director Legal Services Civic Centre Newcastle Upon Tyne Ne1 8qh This Lease Dated the Day of 20 -2
12/34/56
EX-10.10
from S-1 17 pages Executive Employment Agreement Between: MDNA Life Sciences Inc. a Corporation Duly Incorporated Under the Laws of the State of Delaware, (“Mdna”) - And – Robert Poulter, of Gorham, Ontario, Canada
12/34/56
EX-10.9
from S-1 7 pages Executive Employment Agreement
12/34/56
EX-10.8
from S-1 16 pages MDNA Life Sciences Inc. 8% Secured Convertible Note Usd [Info] [Amount Will Vary]
12/34/56
EX-10.7
from S-1 7 pages MDNA Life Sciences, Inc. 10% Secured Convertible Note Due November 17, 2021
12/34/56
EX-10.6
from S-1 14 pages Common Stock Purchase Warrant MDNA Life Sciences, Inc
12/34/56
EX-10.5
from S-1 15 pages 12% Convertible Promissory Note Due __, 2023
12/34/56
EX-10.4
from S-1 22 pages Securities Purchase Agreement
12/34/56
EX-10.3
from S-1 124 pages Securities Purchase Agreement and Escrow Agreement MDNA Life Sciences, Inc. Securities Purchase Agreement
12/34/56
EX-10.2
from S-1 10 pages MDNA Life Sciences Inc. Restricted Stock Unit Plan
12/34/56
EX-10.15
from DRS/A 3 pages Second Amendment to December 22, 2017 License Agreement
12/34/56